In order to provide the most relevant content to the readers of HealthCare Business News, we're asking you to share a little information about who you are, (it takes two seconds and then you're done).
Register
World’s first MR-guided RT system, MRIdian, comes to the U.S. East Coast
In a study currently being conducted, ViewRay is finding its install base is using the MRIdian system two to three times more for hypofractionation than any of the other systems. This ultimately saves money for the patient, hospital, and payor because the number of fractions are significantly reduced.
“The hospitals win because they can get more patients through the systems – because if you only have a five fraction treatment,” said Saracen, “...you’re only taking one-sixth of the treatment volume room. The patient only has to come in five times, verses 30.”
MIT labs, experts in Multi-Vendor component level repair of: MRI Coils, RF amplifiers, Gradient Amplifiers Contrast Media Injectors. System repairs, sub-assembly repairs, component level repairs, refurbish/calibrate. info@mitlabsusa.com/+1 (305) 470-8013
The MRIdian system is also in use at the UCLA Jonsson Comprehensive Cancer Center in Los Angeles, Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in Missouri, the University of Wisconsin Carbone Cancer Center in Wisconsin, and Seoul National University Hospital in Korea.
In the following video radiologists from the University of Wisconsin explain the benefits of MR-guided radiation therapy.
Although ViewRay's backlog of orders almost doubled last year, the company has only generated $5.3 million in sales during the quarter that ended in September, and has yet to turn a profit, according to Crain's Cleveland Business. Still, as evidence accrues for the value of the system — which was reportedly designed in partnership with Siemens — the company expects the sales to increase.
“The traction is good. The clinical results are good. We’re getting the orders we want. We’re getting them from the names and people we want,” Chris Raanes, CEO of ViewRay, told the newspaper.
